German Heart Center
Quick facts
Phase 3 pipeline
- aprotinin or tranexamic acid · Cardiovascular
Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby reducing fibrinolysis and preventing excessive bleeding.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about German Heart Center
What is German Heart Center's pipeline?
German Heart Center has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include aprotinin or tranexamic acid.
Related
- Sector hub: All tracked pharma companies